Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Acquisition

Sat Kartar Life Acquisition Worth ₹1.21 Cr

Sat Kartar Shopping Limited approved the acquisition of a further 24% stake in Plantomed Neutraceuticals Private Limited for ₹1.21 Crore. This transaction will increase the company's control to 100%, making the target a wholly-owned subsidiary. The acquisition aims to consolidate branding and expand the company's Ayurveda and wellness product portfolio by May 2026.

Key figures
Value₹1.21 Cr
Execution period15-05-2026
Source

NSE filing, NSE: SATKARTAR. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Sat Kartar Life Ltd: key numbers

Share price
₹130.35
Market cap
₹205.9 Cr
Revenue (annual)
₹200.7 Cr
Net profit (annual)
₹17.10 Cr
P/E (TTM)
12.0×Sector 46.1×
Promoter holding
63.49%
FII holding
0.77%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sat Kartar Life Ltd

All →

Other acquisition announcements

All →